{"id":1895,"date":"2021-12-15T14:00:00","date_gmt":"2021-12-15T13:00:00","guid":{"rendered":"https:\/\/ancstockinvestments.com\/blog\/?p=1895"},"modified":"2021-12-14T17:32:10","modified_gmt":"2021-12-14T16:32:10","slug":"54gene-launches-7riverlabs-boost-patient-health-outcomes","status":"publish","type":"post","link":"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/","title":{"rendered":"54gene Launches Diagnostic Arm 7RiverLabs to Boost Patient Health Outcomes"},"content":{"rendered":"\n<p>54gene, the health technology company advancing African genomics research for improved global health outcomes, has launched its diagnostic arm, 7RiverLabs.<\/p>\n\n\n\n<p>The diagnostic hubs fitted with state-of-the-art technology will offer healthcare providers and patients access to world-class, cost-effective, speedy, reliable, and advanced molecular diagnostics.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>More about 7RiverLabs<\/strong><\/h2>\n\n\n\n<p>Sample collection centers with over 100 employees are already open in Lagos, Abuja, Kano, and Port Harcourt, with more centers due to launch in 10 major Nigerian cities in the coming months. Pan-African expansion for 7RiverLabs is also planned over the course of 2022.&nbsp;<\/p>\n\n\n\n<p>On the launch of <a href=\"https:\/\/7riverlabs.com\/\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\" (opens in a new tab)\">7RiverLabs<\/a>, 54gene Founder and CEO Dr. Abasi Ene-Obong said, <em>\u201claunching 7RiverLabs is a manifestation of one of the goals 54gene set out to achieve two years ago &#8211; to improve diagnostic and treatment outcomes on the continent.\u201d\u00a0<\/em><\/p>\n\n\n\n<p>With the range of tests 7RiverLabs offers, millions of Africans can begin to take greater control of their health.\u00a0<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"684\" data-src=\"https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7riverLabs-1-Copy-1024x684.jpeg\" alt=\"54gene Launches Diagnostic Arm 7RiverLabs to Boost Patient Health Outcomes\" class=\"wp-image-1896 lazyload\" data-srcset=\"https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7riverLabs-1-Copy-1024x684.jpeg 1024w, https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7riverLabs-1-Copy-300x200.jpeg 300w, https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7riverLabs-1-Copy-768x513.jpeg 768w, https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7riverLabs-1-Copy-1536x1025.jpeg 1536w, https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7riverLabs-1-Copy-2048x1367.jpeg 2048w, https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7riverLabs-1-Copy-1200x801.jpeg 1200w, https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7riverLabs-1-Copy-1980x1322.jpeg 1980w\" data-sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 1024px; --smush-placeholder-aspect-ratio: 1024\/684;\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>54gene: redefining African genomics<\/strong><\/h2>\n\n\n\n<p>Since its launch in 2019, <a href=\"https:\/\/54gene.com\/\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\" (opens in a new tab)\">54gene<\/a> has driven genomics and molecular medicine throughout Africa. Formerly known as DiagnoseMe Africa, 7RiverLabs (named after the 7 major rivers on the continent), is designed to equalize precision medicine for African populations.\u00a0<\/p>\n\n\n\n<p>Building on that vision, 54gene has domesticated diagnostic technology; eliminating the need for samples to be sent abroad for analysis, at a considerable cost to the patient. Physicians will now be able to detect and prevent diseases earlier, thereby helping to improve patients\u2019 treatment outcomes and quality of health.<\/p>\n\n\n\n<p>As part of its mission to establish itself as a principal provider of diagnostic care driven by ultra-modern technology, 54gene has appointed its Chief Business Officer, Jude Uzonwanne as the diagnostic arm\u2019s interim CEO.&nbsp;<\/p>\n\n\n\n<p><em>\u201c7RiverLabs is complementing Government and industry efforts to attain the Nigerian Ministry of Health\u2019s mandate towards improved care for the general population. Hundreds of molecular tests will be made available for millions of people at a fraction of the cost of transporting samples overseas thereby helping to increase early disease-detection and screening rates and save lives,\u201d<\/em> Jude Uzonwanne said.<\/p>\n\n\n\n<p><em>\u201cThis is groundbreaking news for Nigeria; and as we forge trusted partnerships with leading health insurers, hospitals and healthcare professionals, we anticipate that hundreds more jobs will be created in our expansion of services across Africa.\u201d<\/em><\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"684\" data-src=\"https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/7RiverLabs-Copy-1024x684.jpeg\" alt=\"54gene Launches Diagnostic Arm 7RiverLabs to Boost Patient Health Outcomes\" class=\"wp-image-1897 lazyload\" data-srcset=\"https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/7RiverLabs-Copy-1024x684.jpeg 1024w, https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/7RiverLabs-Copy-300x200.jpeg 300w, https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/7RiverLabs-Copy-768x513.jpeg 768w, https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/7RiverLabs-Copy-1536x1025.jpeg 1536w, https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/7RiverLabs-Copy-2048x1367.jpeg 2048w, https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/7RiverLabs-Copy-1200x801.jpeg 1200w, https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/7RiverLabs-Copy-1980x1322.jpeg 1980w\" data-sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 1024px; --smush-placeholder-aspect-ratio: 1024\/684;\" \/><\/figure>\n\n\n\n<p>Through the use of state-of-the-art laboratories and marked workflow improvements, over 300 critical molecular tests can now be performed safely and securely &#8211; covering oncology, infectious diseases, genetic testing and sequencing, anatomic pathology, clinical chemistry, microbiology, haematology, as well as communicable and non-communicable diseases.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Reducing test cost<\/strong><\/h2>\n\n\n\n<p>With some tests costing as little as a few thousand Naira &#8211; generally more affordable than the prevailing market rates &#8211; results, depending on the complexity, are provided in as little time as a few hours to a few days and are sent digitally to patients\u2019 physicians for follow-up.&nbsp;<\/p>\n\n\n\n<p><em>\u201cOur goal with this new diagnostics arm is to ensure that every African has access to our hubs offering advanced laboratory tests without having to pay an exorbitant out-of-pocket fee. Patients will receive speedy results that will guide their physicians in reducing late diagnoses leading to poor chances of survival, improve their treatment options and ultimately their quality of life,\u201d <\/em>Dr. Abasi said.<\/p>\n\n\n\n<p>As of 2021, the addressable market for medical tests in Sub-Saharan Africa is currently worth US$10 billion. At present, the majority of molecular tests are sent outside of the continent; investment in this sector will see the market witness an expected average rate of more than 4% growth per annum.&nbsp;<\/p>\n\n\n\n<p>This will be directly linked to affordability, accurate diagnoses, and lighting quick turnaround times &#8211; all of which 7RiverLabs is positioned to deliver not only in Nigeria but across the continent.\u00a0<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"684\" data-src=\"https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7RiverLabs-2-Copy-1024x684.jpeg\" alt=\"\" class=\"wp-image-1898 lazyload\" data-srcset=\"https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7RiverLabs-2-Copy-1024x684.jpeg 1024w, https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7RiverLabs-2-Copy-300x200.jpeg 300w, https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7RiverLabs-2-Copy-768x513.jpeg 768w, https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7RiverLabs-2-Copy-1536x1025.jpeg 1536w, https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7RiverLabs-2-Copy-2048x1367.jpeg 2048w, https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7RiverLabs-2-Copy-1200x801.jpeg 1200w, https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7RiverLabs-2-Copy-1980x1322.jpeg 1980w\" data-sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 1024px; --smush-placeholder-aspect-ratio: 1024\/684;\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>About 54gene<\/strong><\/h2>\n\n\n\n<p>54gene is a health technology company centered on advancing the field of African genomics to unlock scientific discoveries as well as improve diagnostic and treatment outcomes within Africa and the global community.&nbsp;<\/p>\n\n\n\n<p>Founded in 2019, the company generates genetic insights from research cohorts in the world\u2019s most diverse populations to improve the development, availability, and efficacy of therapeutics and diagnostics that will prove beneficial to all populations.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>54gene has launched its diagnostics arm &#8211; 7RiverLabs, to offer African healthcare providers &#038; patients access to affordable &#038; fast molecular diagnostics.<\/p>\n","protected":false},"author":3,"featured_media":1896,"comment_status":"open","ping_status":"open","sticky":true,"template":"","format":"standard","meta":{"content-type":"","inline_featured_image":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[5,4],"tags":[300,301,302,51],"series":[],"ppma_author":[463],"class_list":["post-1895","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-startup","tag-54gene","tag-7riverlabs","tag-health","tag-startups"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>54gene Launches 7RiverLabs to Boost Patient Health Outcomes<\/title>\n<meta name=\"description\" content=\"54gene has launched its diagnostics arm - 7RiverLabs, to offer African healthcare providers &amp; patients access to affordable &amp; fast molecular diagnostics.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"54gene Launches 7RiverLabs to Boost Patient Health Outcomes\" \/>\n<meta property=\"og:description\" content=\"54gene has launched its diagnostics arm - 7RiverLabs, to offer African healthcare providers &amp; patients access to affordable &amp; fast molecular diagnostics.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/\" \/>\n<meta property=\"og:site_name\" content=\"ANC Blog\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-15T13:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7riverLabs-1-Copy-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1709\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ngwa Emmanuel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ngwa Emmanuel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/\"},\"author\":{\"name\":\"Ngwa Emmanuel\",\"@id\":\"https:\/\/ancstockinvestments.com\/blog\/#\/schema\/person\/12b463b4dc7a31567d2ebb7c5bc2a2f2\"},\"headline\":\"54gene Launches Diagnostic Arm 7RiverLabs to Boost Patient Health Outcomes\",\"datePublished\":\"2021-12-15T13:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/\"},\"wordCount\":689,\"commentCount\":4,\"publisher\":{\"@id\":\"https:\/\/ancstockinvestments.com\/blog\/#organization\"},\"image\":{\"@id\":\"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7riverLabs-1-Copy-scaled.jpeg\",\"keywords\":[\"54gene\",\"7RiverLabs\",\"Health\",\"Startups\"],\"articleSection\":[\"Business\",\"Startup\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/\",\"url\":\"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/\",\"name\":\"54gene Launches 7RiverLabs to Boost Patient Health Outcomes\",\"isPartOf\":{\"@id\":\"https:\/\/ancstockinvestments.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7riverLabs-1-Copy-scaled.jpeg\",\"datePublished\":\"2021-12-15T13:00:00+00:00\",\"description\":\"54gene has launched its diagnostics arm - 7RiverLabs, to offer African healthcare providers & patients access to affordable & fast molecular diagnostics.\",\"breadcrumb\":{\"@id\":\"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/#primaryimage\",\"url\":\"https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7riverLabs-1-Copy-scaled.jpeg\",\"contentUrl\":\"https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7riverLabs-1-Copy-scaled.jpeg\",\"width\":2560,\"height\":1709,\"caption\":\"54gene Launches Diagnostic Arm 7RiverLabs to Boost Patient Health Outcomes\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ancstockinvestments.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"54gene Launches Diagnostic Arm 7RiverLabs to Boost Patient Health Outcomes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ancstockinvestments.com\/blog\/#website\",\"url\":\"https:\/\/ancstockinvestments.com\/blog\/\",\"name\":\"ANC Blog\",\"description\":\"Investing for the Future\",\"publisher\":{\"@id\":\"https:\/\/ancstockinvestments.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ancstockinvestments.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ancstockinvestments.com\/blog\/#organization\",\"name\":\"ANC Blog\",\"url\":\"https:\/\/ancstockinvestments.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ancstockinvestments.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2024\/11\/anc-logo-full-dark.svg\",\"contentUrl\":\"https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2024\/11\/anc-logo-full-dark.svg\",\"width\":839,\"height\":186,\"caption\":\"ANC Blog\"},\"image\":{\"@id\":\"https:\/\/ancstockinvestments.com\/blog\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ancstockinvestments.com\/blog\/#\/schema\/person\/12b463b4dc7a31567d2ebb7c5bc2a2f2\",\"name\":\"Ngwa Emmanuel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ancstockinvestments.com\/blog\/#\/schema\/person\/image\/0e9cd6a0380a4095328c18506f5a024d\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/36012ba548ef861ffb3cfc47da684aae4a714ed8eea8139836775ec6a8b91e0c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/36012ba548ef861ffb3cfc47da684aae4a714ed8eea8139836775ec6a8b91e0c?s=96&d=mm&r=g\",\"caption\":\"Ngwa Emmanuel\"},\"description\":\"Emmanuel crafts insightful data-driven stories on Finance, Forex, Cryptocurrency, Investment, Stocks, and Startups. As Editor-in-Chief at ANC Blog, I help our readers learn the ropes of the finance and startup ecosystem.\",\"url\":\"https:\/\/ancstockinvestments.com\/blog\/author\/ngwa\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"54gene Launches 7RiverLabs to Boost Patient Health Outcomes","description":"54gene has launched its diagnostics arm - 7RiverLabs, to offer African healthcare providers & patients access to affordable & fast molecular diagnostics.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/","og_locale":"en_US","og_type":"article","og_title":"54gene Launches 7RiverLabs to Boost Patient Health Outcomes","og_description":"54gene has launched its diagnostics arm - 7RiverLabs, to offer African healthcare providers & patients access to affordable & fast molecular diagnostics.","og_url":"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/","og_site_name":"ANC Blog","article_published_time":"2021-12-15T13:00:00+00:00","og_image":[{"width":2560,"height":1709,"url":"https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7riverLabs-1-Copy-scaled.jpeg","type":"image\/jpeg"}],"author":"Ngwa Emmanuel","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ngwa Emmanuel","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/#article","isPartOf":{"@id":"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/"},"author":{"name":"Ngwa Emmanuel","@id":"https:\/\/ancstockinvestments.com\/blog\/#\/schema\/person\/12b463b4dc7a31567d2ebb7c5bc2a2f2"},"headline":"54gene Launches Diagnostic Arm 7RiverLabs to Boost Patient Health Outcomes","datePublished":"2021-12-15T13:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/"},"wordCount":689,"commentCount":4,"publisher":{"@id":"https:\/\/ancstockinvestments.com\/blog\/#organization"},"image":{"@id":"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/#primaryimage"},"thumbnailUrl":"https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7riverLabs-1-Copy-scaled.jpeg","keywords":["54gene","7RiverLabs","Health","Startups"],"articleSection":["Business","Startup"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/","url":"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/","name":"54gene Launches 7RiverLabs to Boost Patient Health Outcomes","isPartOf":{"@id":"https:\/\/ancstockinvestments.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/#primaryimage"},"image":{"@id":"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/#primaryimage"},"thumbnailUrl":"https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7riverLabs-1-Copy-scaled.jpeg","datePublished":"2021-12-15T13:00:00+00:00","description":"54gene has launched its diagnostics arm - 7RiverLabs, to offer African healthcare providers & patients access to affordable & fast molecular diagnostics.","breadcrumb":{"@id":"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/#primaryimage","url":"https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7riverLabs-1-Copy-scaled.jpeg","contentUrl":"https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7riverLabs-1-Copy-scaled.jpeg","width":2560,"height":1709,"caption":"54gene Launches Diagnostic Arm 7RiverLabs to Boost Patient Health Outcomes"},{"@type":"BreadcrumbList","@id":"https:\/\/ancstockinvestments.com\/blog\/2021\/12\/15\/54gene-launches-7riverlabs-boost-patient-health-outcomes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ancstockinvestments.com\/blog\/"},{"@type":"ListItem","position":2,"name":"54gene Launches Diagnostic Arm 7RiverLabs to Boost Patient Health Outcomes"}]},{"@type":"WebSite","@id":"https:\/\/ancstockinvestments.com\/blog\/#website","url":"https:\/\/ancstockinvestments.com\/blog\/","name":"ANC Blog","description":"Investing for the Future","publisher":{"@id":"https:\/\/ancstockinvestments.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ancstockinvestments.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ancstockinvestments.com\/blog\/#organization","name":"ANC Blog","url":"https:\/\/ancstockinvestments.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ancstockinvestments.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2024\/11\/anc-logo-full-dark.svg","contentUrl":"https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2024\/11\/anc-logo-full-dark.svg","width":839,"height":186,"caption":"ANC Blog"},"image":{"@id":"https:\/\/ancstockinvestments.com\/blog\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ancstockinvestments.com\/blog\/#\/schema\/person\/12b463b4dc7a31567d2ebb7c5bc2a2f2","name":"Ngwa Emmanuel","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ancstockinvestments.com\/blog\/#\/schema\/person\/image\/0e9cd6a0380a4095328c18506f5a024d","url":"https:\/\/secure.gravatar.com\/avatar\/36012ba548ef861ffb3cfc47da684aae4a714ed8eea8139836775ec6a8b91e0c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/36012ba548ef861ffb3cfc47da684aae4a714ed8eea8139836775ec6a8b91e0c?s=96&d=mm&r=g","caption":"Ngwa Emmanuel"},"description":"Emmanuel crafts insightful data-driven stories on Finance, Forex, Cryptocurrency, Investment, Stocks, and Startups. As Editor-in-Chief at ANC Blog, I help our readers learn the ropes of the finance and startup ecosystem.","url":"https:\/\/ancstockinvestments.com\/blog\/author\/ngwa\/"}]}},"jetpack_featured_media_url":"https:\/\/ancstockinvestments.com\/blog\/wp-content\/uploads\/2021\/12\/54gene-Launches-7riverLabs-1-Copy-scaled.jpeg","jetpack_sharing_enabled":true,"authors":[{"term_id":463,"user_id":3,"is_guest":0,"slug":"ngwa","display_name":"Ngwa Emmanuel","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/36012ba548ef861ffb3cfc47da684aae4a714ed8eea8139836775ec6a8b91e0c?s=96&d=mm&r=g","author_category":"","user_url":"","last_name":"Emmanuel","first_name":"Ngwa","job_title":"","description":"Emmanuel crafts insightful data-driven stories on Finance, Forex, Cryptocurrency, Investment, Stocks, and Startups. As Editor-in-Chief at ANC Blog, I help our readers learn the ropes of the finance and startup ecosystem."}],"_links":{"self":[{"href":"https:\/\/ancstockinvestments.com\/blog\/wp-json\/wp\/v2\/posts\/1895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ancstockinvestments.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ancstockinvestments.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ancstockinvestments.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ancstockinvestments.com\/blog\/wp-json\/wp\/v2\/comments?post=1895"}],"version-history":[{"count":1,"href":"https:\/\/ancstockinvestments.com\/blog\/wp-json\/wp\/v2\/posts\/1895\/revisions"}],"predecessor-version":[{"id":1899,"href":"https:\/\/ancstockinvestments.com\/blog\/wp-json\/wp\/v2\/posts\/1895\/revisions\/1899"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ancstockinvestments.com\/blog\/wp-json\/wp\/v2\/media\/1896"}],"wp:attachment":[{"href":"https:\/\/ancstockinvestments.com\/blog\/wp-json\/wp\/v2\/media?parent=1895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ancstockinvestments.com\/blog\/wp-json\/wp\/v2\/categories?post=1895"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ancstockinvestments.com\/blog\/wp-json\/wp\/v2\/tags?post=1895"},{"taxonomy":"series","embeddable":true,"href":"https:\/\/ancstockinvestments.com\/blog\/wp-json\/wp\/v2\/series?post=1895"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/ancstockinvestments.com\/blog\/wp-json\/wp\/v2\/ppma_author?post=1895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}